This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Children's Medical Center Corporation, The General Hospital Corporation. Active years: 2016-2019.
Company Filing History:
3 out of 1,072 
1 out of 3,068 
Years Active: 2016-2019
Title: Deepika Nehra: Innovator in Cancer Treatment
Introduction
Deepika Nehra is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 3 patents, her work focuses on therapeutic targets that aim to improve the lives of those affected by various cancers.
Latest Patents
One of her latest patents is centered around a therapeutic target for the treatment of cancers and related therapies and methods. This patent discloses compositions and methods for treating or preventing certain cancers in a subject. Specifically, it relates to the use of G-coupled protein receptor 40 (GPR40) agonists to inhibit the growth or induce apoptosis of certain cancer cells. The compositions and related methods may be utilized to treat subjects affected by cancers such as melanoma, medullary thyroid carcinoma, malignant peripheral nerve sheath tumors, and neuroblastoma. Additionally, her work aims to reduce the incidence of metastases in affected subjects.
Career Highlights
Throughout her career, Deepika Nehra has worked with notable organizations, including Children's Medical Center Corporation and The General Hospital Corporation. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Mark Puder and Brian Kalish. Their collaboration has further enhanced the impact of her research and innovations in cancer treatment.
Conclusion
Deepika Nehra's contributions to cancer research and treatment through her patents and collaborations highlight her dedication to improving patient outcomes. Her innovative approaches continue to pave the way for advancements in the medical field.